FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome's CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Molecular Diagnostics
Latest
BioView Unveils Breakthrough Liquid Biopsy for HER2 Detection in Metastatic Breast Cancer
BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.
How Cancer ‘Fingerprint’ Can Improve Early Detection
Researchers identified unique molecular “fingerprints” on ribosomes that can detect early-stage cancers using nanopore sequencing devices.
Read More
Doylestown Health: Taking Laboratory Testing In-House
While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.
Read More
Genomic Testing Advances Lynch Syndrome Diagnosis and Cancer Treatment
A new study highlights the critical role of genomic testing in diagnosing Lynch syndrome and guiding treatment for inherited cancers.
Read More
Genomic Sequencing Platform Found Effective for Newborn Screening
Two studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read More
Potential Epigenetic Biomarker for Preeclampsia Identified
Researchers have identified a potential epigenetic biomarker for preeclampsia, offering hope for earlier diagnosis and intervention.
Read More
GeneDx Names Partners for Epilepsy Diagnostic Program
GeneDx named the partners of its Patient Access Program that provides whole exome sequencing for pediatric epilepsy.
Read More
Delve Bio Launches Genomic Infectious Disease Test Delve Detect
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read More
CMS Finalizes 2025 Pricing for 3D Genomics Cancer Test
Aventa Genomics received CMS approval for Clinical Laboratory Fee Schedule pricing of an NGS tool that uses 3D genomics for cancer testing.
Read More
Biofidelity’s Aspyre Lung Delivers Accurate Molecular Diagnostics for NSCLC Variants
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read More
OncoHost Proteomics Lab Earns CAP Accreditation
OncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read More
Mission Bio Announces Partnership to Advance Multiple Myeloma Insights
Mission Bio’s collaboration will leverage single-cell DNA analysis for insights into multiple myeloma relapse and treatment strategies.
Read More
Combination of VIGex Gene Expression Signature and Liquid Biopsy May Improve Response Prediction to Immunotherapy
A study shows that combining the VIGex gene expression signature with ctDNA analysis can enhance the prediction of immunotherapy response.
Read More
DNA Breathing Provides Genomic Prediction Power
Scientists have developed a deep learning model that utilizes DNA breathing to predict transcription factor binding.
Read More
Genetic Testing May Revolutionize Pain Management Amid Opioid Crisis
A new study shows how genetic testing could personalize postoperative pain management by identifying genetic predispositions to opioid use.
Read More
How mNGS Testing Delivers Unmatched Pathogen Detection in Infectious Diseases
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read More